No Matches Found
No Matches Found
No Matches Found
Is Illumina, Inc. overvalued or undervalued?
As of October 31, 2025, Illumina, Inc. is considered overvalued with a valuation grade of expensive, highlighted by a P/E ratio of 26 and underperformance against the S&P 500, despite a low PEG ratio of 0.07.
Is Illumina, Inc. technically bullish or bearish?
As of October 31, 2025, Illumina, Inc. shows a mildly bullish technical trend supported by positive MACD and Bollinger Bands, despite mixed signals from the KST and concerning long-term performance, with a year-to-date return of -10.21%.
Is Illumina, Inc. overvalued or undervalued?
As of October 31, 2025, Illumina, Inc. is considered overvalued with a P/E ratio of 26, significantly higher than its peers, and has underperformed the S&P 500 with a year-to-date return of -10.21% and a 5-year return of -58.38%.
Illumina Stock Soars 24.78%, Hits Intraday High of $123.91
Illumina, Inc. has seen notable stock activity, with a significant intraday high and a strong weekly performance. Despite recent challenges reflected in longer-term returns, the company reported impressive net profit growth and maintains a low debt-to-equity ratio, indicating a solid financial position amidst market fluctuations.
Illumina, Inc. Experiences Valuation Adjustment Amid Competitive Market Landscape
Illumina, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 26 and a Price to Book Value of 6.89. The company demonstrates strong operational efficiency with an EV to EBIT of 12.09 and a ROCE of 44.33%, reflecting its competitive position in the Pharmaceuticals & Biotechnology sector.
Is Illumina, Inc. technically bullish or bearish?
As of October 31, 2025, Illumina, Inc. shows a mildly bullish technical trend supported by bullish MACD and Bollinger Bands, despite some bearish indicators, while outperforming the S&P 500 in the short term but underperforming year-to-date.
Is Illumina, Inc. overvalued or undervalued?
As of October 31, 2025, Illumina, Inc. is considered overvalued with a P/E ratio of 26 compared to the industry average of 19.09, a high EV to EBITDA ratio of 9.89, and a low PEG ratio of 0.07, while its stock has underperformed with a -14.29% return over the past year.
Is Illumina, Inc. technically bullish or bearish?
As of October 31, 2025, Illumina, Inc. shows a mildly bullish technical trend, supported by positive MACD and Bollinger Bands, but mixed signals from KST and OBV suggest caution despite recent outperformance against the S&P 500.
Is Illumina, Inc. overvalued or undervalued?
As of October 31, 2025, Illumina, Inc. is considered overvalued with a valuation grade of expensive, reflected in its high P/E ratio of 26 and underperformance against the S&P 500, showing a year-to-date return of -7.55% compared to the index's 16.30%.
Illumina, Inc. Experiences Valuation Adjustment Amidst Challenging Market Performance
Illumina, Inc. has recently adjusted its valuation, with its current price at $95.46. Over the past year, the company has experienced a significant decline of 33.49%, contrasting with the S&P 500's positive performance. Key financial metrics indicate operational efficiency but suggest a premium valuation compared to industry peers.
Illumina, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges
Illumina, Inc. has faced significant challenges over the past year, with its stock price declining and a notable negative return compared to the S&P 500. Technical indicators present a mixed outlook, reflecting volatility and a struggle to regain stability in a fluctuating market environment.
Is Illumina, Inc. technically bullish or bearish?
As of October 10, 2025, Illumina, Inc. shows a neutral technical trend with mixed signals, underperforming the S&P 500 significantly with year-to-date and one-year returns of -29.76% and -34.71%, respectively.
Is Illumina, Inc. technically bullish or bearish?
As of October 10, 2025, Illumina, Inc. shows a neutral technical trend with mixed indicators, including mildly bullish weekly and monthly MACD but bearish signals from Bollinger Bands and KST, while significantly underperforming the S&P 500 with year-to-date and one-year returns of -29.76% and -34.71%, respectively.
Illumina, Inc. Experiences Evaluation Revision Amidst Ongoing Market Challenges
Illumina, Inc. has recently revised its evaluation amid ongoing market challenges, with its stock priced at $101.02. Over the past year, the company has experienced a significant decline, contrasting with the S&P 500's gains. Technical indicators present a mixed outlook, reflecting the company's competitive landscape.
Is Illumina, Inc. technically bullish or bearish?
As of October 3, 2025, Illumina, Inc. shows a mildly bullish technical trend despite mixed signals from KST and Bollinger Bands, while underperforming the S&P 500 with a year-to-date return of -24.40%.
Illumina, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics
Illumina, Inc. has recently adjusted its valuation, with a current P/E ratio of 26 and a price-to-book value of 6.89. The company exhibits strong operational efficiency, reflected in its high ROCE of 44.33% and ROE of 26.59%. Its stock performance has lagged behind the S&P 500 this year.
Illumina Stock Forms Golden Cross, Signaling Potential Bullish Breakout
Illumina, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock has outperformed the S&P 500 with a notable daily increase and a strong weekly gain, despite a challenging year-to-date performance. Technical indicators show a mix of bullish and cautious signals.
Is Illumina, Inc. technically bullish or bearish?
As of October 3, 2025, Illumina, Inc. shows a mildly bullish trend with positive momentum indicators, but caution is advised due to mixed signals and significant underperformance compared to the S&P 500.
Is Illumina, Inc. technically bullish or bearish?
As of October 3, 2025, Illumina, Inc. shows a mildly bullish trend with positive momentum from weekly and daily indicators, but caution is advised due to mixed signals and significant underperformance compared to the S&P 500.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}

